TARA
Protara Therapeutics·NASDAQ
--
--(--)
--
--(--)
TARA Filings
Filing Date
Form Description
Form Type
2026-04-01
Form 144 - Report of proposed sale of securities
Ownership
2026-04-01 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-30
Form 8-K - Current report
Key Events
2026-03-30 · Key Events
Form 8-K - Current report
2026-03-10
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-10 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-10
Form 8-K - Current report
Key Events
2026-03-10 · Key Events
Form 8-K - Current report
2026-03-06
Form 144 - Report of proposed sale of securities
Ownership
2026-03-06 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-06
Form 144 - Report of proposed sale of securities
Ownership
2026-03-06 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-06
Form 424B7 - Prospectus [Rule 424(b)(7)]
2026-03-06 ·
Form 424B7 - Prospectus [Rule 424(b)(7)]
2026-03-04
Form 144 - Report of proposed sale of securities
Ownership
2026-03-04 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-04
Form 144 - Report of proposed sale of securities
Ownership
2026-03-04 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-02
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-03-02 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
